The skull heals its cracks, the bruises fade, the swelling subsides and the bleeding stops. From the outside, a traumatic blow to the head, whether from a battlefield blast, car crash or even a tackle gone wrong, may seem ...
Jul 16, 2026
0
11
As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. ...
Jul 16, 2026
0
6
Scientists have, for the first time, mapped in exquisite three-dimensional detail six major conformations of a membrane in the brain related to learning, memory and fear-related behavior.
Jul 16, 2026
0
4
The official sum of opioid-related settlements between U.S. state and local governments and major pharmaceutical opioid manufacturers, marketers, distributors and retailers recently reached $58.58 billion. Stark statistics ...
Jul 16, 2026
0
13
A new daily pill will give people with stubbornly high cholesterol a cheaper, needle-free way to lower their levels.
Jul 16, 2026
0
11
A study by researchers at Kent has revealed that the narcotic analgesic tapentadol has performance-enhancing effects on cyclists, making this drug a candidate for addition to the World Anti-Doping Agency's (WADA) list of ...
Jul 16, 2026
0
5
A new drug offers hope for people with hypertrophic cardiomyopathy, the world's most common inherited heart disease. The TEMPEST trial, led by University of Manchester researchers, tested the drug—called trientine—in 154 ...
Jul 16, 2026
0
4
For many people with Parkinson's disease, the body stops moving the way it used to. A hand may tremble at rest. Muscles may stiffen. Walking can become slower and balance more uncertain. The most effective treatment remains ...
Jul 15, 2026
0
7
Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drugs, often given to patients for whom standard chemotherapy has not worked. ...
Jul 15, 2026
0
7
The early-stage trial of a potential novel nonartemisinin malaria drug found it rapidly killed malaria parasites and was generally well tolerated in infected volunteers, showing it is a promising candidate for uncomplicated ...
Jul 15, 2026
0
6
